Barbara Ryan, Director at INVO Bioscience, Inc. (INVO), bought 10,526 shares at $0.95 ($10K) on 2022-06-01, disclosed to the SEC on 2022-06-03.
Open-market purchase of $10k INVO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Clearly above the average filing.
| Filing → |
| INDV | BUY | 2026-03-11 | $1K | — | Filing → |
| INKT | SELL | 2026-03-11 | $36K | — | Filing → |
| INKT | SELL | 2026-03-04 | $5K | — | Filing → |